Skip to main content
Download PDF
  • ORIGINAL
  • Published:

A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache

The Journal of Headache and Pain volume 5, pages 192–196 (2004)Cite this article

Abstract

The objective was to measure the cost of botulinum toxin type A (BTX-A) treatment of chronic tension-type headache. A prospective pharmaceutical costing analysis was completed in the Day Hospital of the Regional Referral Headache Centre at Sant’Andrea Hospital in Rome, chronic tension-type headache patients were treated from February 2003 to January 2004. Patients were treated with 100 U of BTX-A every three months for one year by using the Fixed Doses Fixed Sites procedure. The cost of treatment was based on drug acquisition costs, supplies and professional time needed to administer treatment. The average cost of conventional headache medications was € 853.43 before BTX-A treatment, and € 450.47 after. The cost of BTX-A treatment was € 642.00. Adding the cost of adjunctive conventional medications brought the total cost of BTX-A treatment to € 1092.47. BTX-A treatment reduced use of conventional headache medications and expenditures although the net cost of treatment increased with BTX-A use.

Author information

Authors and Affiliations

  1. National Research Council, Institute for Population Research and Social Policies, Rome, Italy

    Fabio Palazzo

  2. CEIS Centre for Health Economics and Health Care Management, School of Economics, University of Rome Tor Vergata, Rome, Italy

    Francesco G. Mennini, Laura Fioravanti & Laura Piasini

  3. Department of Internal Medicine, Regional Referral Headache Centre, 2nd School of Medicine, University of Rome La Sapienza, Sant’Andrea Hospital, Via di Grottarossa 1035, I-00189, Rome, Italy

    Gabriella Coloprisco & Paolo Martelletti

Authors
  1. Fabio Palazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Francesco G. Mennini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Fioravanti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laura Piasini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gabriella Coloprisco
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Paolo Martelletti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo Martelletti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palazzo, F., Mennini, F.G., Fioravanti, L. et al. A one-year prospective costing study of botulinum toxin type A treatment of chronic tension headache. J Headache Pain 5, 192–196 (2004). https://doi.org/10.1007/s10194-004-0100-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10194-004-0100-3

Key words

The Journal of Headache and Pain

ISSN: 1129-2377

Contact us